|
|||||
|
|

Regional banking company WesBanco (NASDAQ:WSBC) met Wall Streets revenue expectations in Q4 CY2025, with sales up 63% year on year to $266.2 million. Its non-GAAP profit of $0.84 per share was 1.2% below analysts’ consensus estimates.
Is now the time to buy WSBC? Find out in our full research report (it’s free for active Edge members).
WesBanco’s fourth quarter saw a negative market reaction, with shares declining over 3.5% following results that met Wall Street’s revenue expectations but modestly missed on non-GAAP earnings per share. Management attributed quarterly performance to successful integration of its Premier Financial acquisition, robust deposit growth that fully funded loan expansion, and continued cost discipline, as highlighted by CEO Jeffrey Jackson. Despite elevated commercial real estate (CRE) loan payoffs, the bank achieved organic loan growth and maintained stable credit quality metrics. CFO Daniel Weiss emphasized operational efficiency and margin expansion, while noting that higher expenses reflected the enlarged asset base and integration costs. Strategic actions such as optimizing funding costs and investing in new markets were discussed as key pillars of the quarter’s results.
Looking ahead, WesBanco’s outlook is shaped by expectations for mid-single-digit loan growth, ongoing CRE loan payoffs, and continued expansion in new markets through loan production offices and its health care vertical. Management highlighted opportunities for further margin improvement through repricing CDs and securities, and cost savings from recent branch closures. CEO Jeffrey Jackson sees the health care lending team and Southeast market expansion as primary growth engines. CFO Daniel Weiss guided to a flattish net interest margin in the near term, with incremental improvement later in the year, stating, “we feel pretty comfortable... that we can get into that high 360s in that back half of the year.”
WesBanco’s management credited quarterly results to organic loan growth, cost control, and the ongoing benefits of the Premier Financial integration, while addressing headwinds from elevated CRE payoffs.
Management expects loan growth, expense control, and revenue diversification to shape performance in the coming year amid persistent CRE payoffs and evolving market conditions.
In the coming quarters, our team will watch (1) the pace of organic loan growth versus CRE portfolio runoff, (2) the realization of cost savings from branch closures and the impact of further network optimization, and (3) the success of new market initiatives, particularly in health care lending and Southeast expansion. Continued progress in deposit growth and revenue diversification will also be key to monitoring WesBanco’s strategy execution.
WesBanco currently trades at $34.00, down from $35.22 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| Mar-05 | |
| Feb-22 | |
| Feb-18 | |
| Feb-16 | |
| Feb-16 | |
| Feb-03 | |
| Jan-30 | |
| Jan-28 | |
| Jan-28 | |
| Jan-28 | |
| Jan-27 | |
| Jan-27 | |
| Jan-27 | |
| Jan-27 | |
| Jan-27 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite